Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glucan 1,4-alpha-glucosidase activity	MGAM MGAM2	3.01e-05	2	110	2	GO:0004339
GeneOntologyMolecularFunction	3' overhang single-stranded DNA endodeoxyribonuclease activity	ERCC4 XRCC1	1.79e-04	4	110	2	GO:1990599
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM MGAM2	2.97e-04	5	110	2	GO:0004558
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	1.15e-05	9	108	3	GO:0160063
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	1.13e-05	9	109	3	GO:0160064
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	4.81e-05	14	109	3	GO:0072379
GeneOntologyCellularComponent	Z disc	ANK2 PDLIM7 RYR3 PPP3CB RTL1 FBXO32	1.41e-04	151	109	6	GO:0030018
GeneOntologyCellularComponent	I band	ANK2 PDLIM7 RYR3 PPP3CB RTL1 FBXO32	2.36e-04	166	109	6	GO:0031674
GeneOntologyCellularComponent	ERCC4-ERCC1 complex	ERCC4 XRCC1	2.67e-04	5	109	2	GO:0070522
GeneOntologyCellularComponent	endoplasmic reticulum membrane	HSP90B1 CYP4B1 HLA-DQA2 APOB TESPA1 RYR3 NOMO1 KSR1 OSBP RNF103 NOMO2 MTOR SEC16A TRPM1 NOMO3 GABBR1	1.07e-03	1293	109	16	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	HSP90B1 CYP4B1 HLA-DQA2 APOB TESPA1 RYR3 NOMO1 KSR1 OSBP RNF103 NOMO2 MTOR SEC16A TRPM1 NOMO3 GABBR1	1.13e-03	1299	109	16	GO:0098827
GeneOntologyCellularComponent	NLS-dependent protein nuclear import complex	KPNA4 KPNA3	1.18e-03	10	109	2	GO:0042564
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	HSP90B1 CYP4B1 HLA-DQA2 APOB TESPA1 RYR3 NOMO1 KSR1 OSBP RNF103 NOMO2 MTOR SEC16A TRPM1 NOMO3 GABBR1	1.41e-03	1327	109	16	GO:0042175
GeneOntologyCellularComponent	nucleocytoplasmic transport complex	KPNA4 KPNA3	1.72e-03	12	109	2	GO:0031074
GeneOntologyCellularComponent	smooth endoplasmic reticulum	HSP90B1 APOB RYR3	1.78e-03	46	109	3	GO:0005790
GeneOntologyCellularComponent	cell projection membrane	GPI PSG1 P2RY12 SLC26A4 ADGRV1 KSR1 GABBR1 WWC1	1.90e-03	431	109	8	GO:0031253
GeneOntologyCellularComponent	sarcomere	ANK2 PDLIM7 RYR3 PPP3CB RTL1 FBXO32	1.96e-03	249	109	6	GO:0030017
GeneOntologyCellularComponent	nucleotide-excision repair complex	ERCC4 XRCC1	2.02e-03	13	109	2	GO:0000109
GeneOntologyCellularComponent	X chromosome	SIN3B SMCHD1	2.02e-03	13	109	2	GO:0000805
Domain	DUF2012	NOMO1 NOMO2 NOMO3	7.70e-07	4	109	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	7.70e-07	4	109	3	IPR019008
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	1.06e-05	8	109	3	IPR013784
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	5.30e-05	13	109	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	5.30e-05	13	109	3	2.60.40.1120
Domain	-	PKHD1L1 B4GALNT3	1.01e-04	3	109	2	3.90.182.10
Domain	PA14	PKHD1L1 B4GALNT3	1.01e-04	3	109	2	SM00758
Domain	PA14	PKHD1L1 B4GALNT3	1.01e-04	3	109	2	PF07691
Domain	PA14_dom	PKHD1L1 B4GALNT3	1.01e-04	3	109	2	IPR011658
Domain	IRSp53/IRTKS/Pinkbar	BAIAP2L1 BAIAP2L2	1.01e-04	3	109	2	IPR027681
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	1.24e-04	17	109	3	IPR008969
Domain	-	PSG1 HLA-DQA2 FSD1 PKHD1L1 LEPR PTK7 NOMO1 NOMO2 ROS1 TGM7 ALCAM CAMTA1 NOMO3	1.29e-04	663	109	13	2.60.40.10
Domain	Gal_mutarotase_N	MGAM MGAM2	2.01e-04	4	109	2	IPR031727
Domain	NtCtMGAM_N	MGAM MGAM2	2.01e-04	4	109	2	PF16863
Domain	-	HSP90B1 SMCHD1 SACS	2.05e-04	20	109	3	3.30.565.10
Domain	HATPase_C	HSP90B1 SMCHD1 SACS	2.38e-04	21	109	3	IPR003594
Domain	Ig-like_fold	PSG1 HLA-DQA2 FSD1 PKHD1L1 LEPR PTK7 NOMO1 NOMO2 ROS1 TGM7 ALCAM CAMTA1 NOMO3	2.39e-04	706	109	13	IPR013783
Domain	IMD	BAIAP2L1 BAIAP2L2	3.34e-04	5	109	2	PS51338
Domain	IMD	BAIAP2L1 BAIAP2L2	4.99e-04	6	109	2	PF08397
Domain	Glyco_hydro_31_AS	MGAM MGAM2	4.99e-04	6	109	2	IPR030458
Domain	Glyco_hydro_31	MGAM MGAM2	6.95e-04	7	109	2	IPR000322
Domain	Arm_3	KPNA4 KPNA3	6.95e-04	7	109	2	PF16186
Domain	Importing_su_alpha	KPNA4 KPNA3	6.95e-04	7	109	2	IPR024931
Domain	IBB	KPNA4 KPNA3	6.95e-04	7	109	2	PF01749
Domain	Glyco_hydro_31	MGAM MGAM2	6.95e-04	7	109	2	PF01055
Domain	Arm_3	KPNA4 KPNA3	6.95e-04	7	109	2	IPR032413
Domain	GLYCOSYL_HYDROL_F31_1	MGAM MGAM2	6.95e-04	7	109	2	PS00129
Domain	ARM-type_fold	KPNA4 XPO4 APOB NCDN RYR3 MTOR IQCB1 KPNA3	8.41e-04	339	109	8	IPR016024
Domain	IBB	KPNA4 KPNA3	9.24e-04	8	109	2	PS51214
Domain	Trefoil	MGAM MGAM2	9.24e-04	8	109	2	PF00088
Domain	P_TREFOIL_2	MGAM MGAM2	1.18e-03	9	109	2	PS51448
Domain	Importin-a_IBB	KPNA4 KPNA3	1.18e-03	9	109	2	IPR002652
Domain	PD	MGAM MGAM2	1.18e-03	9	109	2	SM00018
Domain	-	MGAM MGAM2	1.79e-03	11	109	2	4.10.110.10
Domain	P_trefoil_dom	MGAM MGAM2	2.14e-03	12	109	2	IPR000519
Domain	RECEPTOR_TYR_KIN_II	PTK7 ROS1	2.14e-03	12	109	2	PS00239
Domain	I-BAR_dom	BAIAP2L1 BAIAP2L2	2.52e-03	13	109	2	IPR013606
Domain	p53-like_TF_DNA-bd	RUNX3 STAT3 MGA	3.66e-03	53	109	3	IPR008967
Domain	Gal_mutarotase_SF_dom	MGAM MGAM2	4.33e-03	17	109	2	IPR011013
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	KPNA4 CTDSPL2 PDLIM7 FSD1 CIC KIAA1671 BAIAP2L1 TPX2 CAMTA1 CAMSAP1 MGA GAREM1 KPNA3	1.84e-09	430	114	13	35044719
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	3.43e-08	3	114	3	36011023
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	3.43e-08	3	114	3	25576386
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	1.37e-07	4	114	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	1.37e-07	4	114	3	9267806
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	GPI RRP1B CTDSPL2 SMCHD1 DHX38 XRCC1 MDN1 BAIAP2L1 PSMG1 TPX2 MGA KPNA3	1.99e-07	533	114	12	30554943
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	1.90e-06	8	114	3	15257293
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	2.84e-06	9	114	3	36261522
Pubmed	Hepatic lipase maturation: a partial proteome of interacting factors.	HSP90B1 NOMO1 NOMO2 NOMO3	3.22e-06	31	114	4	19136429
Pubmed	SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia.	KPNA4 CTDSPL2 KPNA3	4.05e-06	10	114	3	35021089
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	5.55e-06	11	114	3	32820719
Pubmed	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.	KPNA4 STAT3 KPNA3	9.58e-06	13	114	3	34950606
Pubmed	Leptin receptor is involved in STAT3 activation in human colorectal adenoma.	LEPR STAT3	1.07e-05	2	114	2	21166956
Pubmed	[Polymorphisms in XRCC1 and ERCC4/XPF DNA repair genes and associations with breast cancer risk in women].	ERCC4 XRCC1	1.07e-05	2	114	2	17682675
Pubmed	BAIAP2L1 and BAIAP2L2 differently regulate hair cell stereocilia morphology.	BAIAP2L1 BAIAP2L2	1.07e-05	2	114	2	39093051
Pubmed	Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression.	LEPR STAT3	1.07e-05	2	114	2	21720710
Pubmed	Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.	STAT3 MTOR	1.07e-05	2	114	2	33448097
Pubmed	Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemia.	LEPR STAT3	1.07e-05	2	114	2	21067751
Pubmed	Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL.	STAT3 MTOR	1.07e-05	2	114	2	28082737
Pubmed	Identification of the leptin receptor sequences crucial for the STAT3-Independent control of metabolism.	LEPR STAT3	1.07e-05	2	114	2	32029227
Pubmed	Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes.	NR4A2 CIC	1.07e-05	2	114	2	30504930
Pubmed	Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling.	STAT3 MTOR	1.07e-05	2	114	2	26191214
Pubmed	Expression of leptin receptor (Ob-R) isoforms and signal transducers and activators of transcription (STATs) mRNAs in the mouse taste buds.	LEPR STAT3	1.07e-05	2	114	2	14527166
Pubmed	Specific physiological roles for signal transducer and activator of transcription 3 in leptin receptor-expressing neurons.	LEPR STAT3	1.07e-05	2	114	2	18096691
Pubmed	Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation.	LEPR STAT3	1.07e-05	2	114	2	15070774
Pubmed	Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans.	ERCC4 XRCC1	1.07e-05	2	114	2	9485007
Pubmed	Effects of mTOR-STAT3 on the migration and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer.	STAT3 MTOR	1.07e-05	2	114	2	25063062
Pubmed	The Calcineurin Variant CnAβ1 Controls Mouse Embryonic Stem Cell Differentiation by Directing mTORC2 Membrane Localization and Activation.	PPP3CB MTOR	1.07e-05	2	114	2	27746127
Pubmed	Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors.	MYCN MTOR	1.07e-05	2	114	2	27438153
Pubmed	Disruption of leptin receptor-STAT3 signaling enhances leukotriene production and pulmonary host defense against pneumococcal pneumonia.	LEPR STAT3	1.07e-05	2	114	2	21148797
Pubmed	Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine.	LEPR FBXO32	1.07e-05	2	114	2	20522589
Pubmed	Gamma-aminobutyric acid binds to GABAb receptor to inhibit cholangiocarcinoma cells growth via the JAK/STAT3 pathway.	STAT3 GABBR1	1.07e-05	2	114	2	23007731
Pubmed	PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-beta-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase.	GPI STAT3	1.07e-05	2	114	2	19819066
Pubmed	Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice.	LEPR STAT3	1.07e-05	2	114	2	19052144
Pubmed	Systematic Review: Models of Changes in Gene Expression of MTOR, MURF-1, and MAFBX in Rats and Mice.	MTOR FBXO32	1.07e-05	2	114	2	32421985
Pubmed	Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population.	ERCC4 XRCC1	1.07e-05	2	114	2	21423097
Pubmed	Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity.	MYCN GLDC	1.07e-05	2	114	2	31444411
Pubmed	Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis.	LEPR STAT3	1.07e-05	2	114	2	16054060
Pubmed	mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3.	STAT3 MTOR	1.07e-05	2	114	2	19331815
Pubmed	Leucine promotes leptin receptor expression in mouse C2C12 myotubes through the mTOR pathway.	LEPR MTOR	1.07e-05	2	114	2	20151325
Pubmed	STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance.	LEPR STAT3	1.07e-05	2	114	2	28729467
Pubmed	Cellular Importin-α3 Expression Dynamics in the Lung Regulate Antiviral Response Pathways against Influenza A Virus Infection.	KPNA4 KPNA3	1.07e-05	2	114	2	32320654
Pubmed	Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.	MTOR ROS1	1.07e-05	2	114	2	31053160
Pubmed	Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.	LEPR MTOR	1.07e-05	2	114	2	30621510
Pubmed	Downregulation of N-myc Interactor Promotes Cervical Cancer Cells Growth by Activating Stat3 Signaling.	MYCN STAT3	1.07e-05	2	114	2	33106998
Pubmed	XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.	ERCC4 XRCC1	1.07e-05	2	114	2	21277872
Pubmed	Activated STAT3 Is a Novel Regulator of the XRCC1 Promoter and Selectively Increases XRCC1 Protein Levels in Triple Negative Breast Cancer.	XRCC1 STAT3	1.07e-05	2	114	2	34067421
Pubmed	Genetic loss of importin α4 causes abnormal sperm morphology and impacts on male fertility in mouse.	KPNA4 KPNA3	1.07e-05	2	114	2	33058343
Pubmed	Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.	STAT3 MTOR	1.07e-05	2	114	2	28351321
Pubmed	Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line.	MTOR FBXO32	1.07e-05	2	114	2	18616983
Pubmed	Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation.	APOB MTOR	1.07e-05	2	114	2	17698027
Pubmed	Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.	MYCN MTOR	1.07e-05	2	114	2	22907398
Pubmed	Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders.	APOB SACS	1.07e-05	2	114	2	23043354
Pubmed	Japanese Encephalitis Virus NS5 Inhibits Type I Interferon (IFN) Production by Blocking the Nuclear Translocation of IFN Regulatory Factor 3 and NF-κB.	KPNA4 KPNA3	1.07e-05	2	114	2	28179530
Pubmed	PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages.	SELPLG MTOR	1.07e-05	2	114	2	17245434
Pubmed	Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR.	STAT3 MTOR	1.07e-05	2	114	2	10660304
Pubmed	Leptin Signaling Is Not Required for Anorexigenic Estradiol Effects in Female Mice.	LEPR STAT3	1.07e-05	2	114	2	26937712
Pubmed	P-selectin glycoprotein ligand-1 deficiency is protective against obesity-related insulin resistance.	SELPLG LEPR	1.07e-05	2	114	2	20971965
Pubmed	Glucose Increases STAT3 Activation, Promoting Sustained XRCC1 Expression and Increasing DNA Repair.	XRCC1 STAT3	1.07e-05	2	114	2	35457130
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPI SIN3B HSP90B1 ANK2 ERCC6L SMCHD1 DHX38 CIC STAT3 KIAA1671 TPX2 SEC16A CAMSAP1	1.24e-05	934	114	13	33916271
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SIN3B ERCC6L PDLIM7 SMCHD1 STAT3 KIAA1671 KMT2C TPX2 SEC16A MGA	1.39e-05	549	114	10	38280479
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MYCN ERCC6L CTDSPL2 NR4A2 XRCC1 CIC KMT2C KSR1 MDN1 MGA FBXO34	1.73e-05	689	114	11	36543142
Pubmed	Nur77 deletion impairs muscle growth during developmental myogenesis and muscle regeneration in mice.	NR4A2 MTOR FBXO32	1.86e-05	16	114	3	28170423
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ANK2 ERCC6L APOB PTK7 PPP3CB BAIAP2L1 MTOR ALCAM SLITRK6 CAMSAP1	1.89e-05	569	114	10	30639242
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ERCC6L FSD1 CIC STAT3 KIAA1671 KSR1 MDN1 BAIAP2L1 MTOR IQCB1 SEC16A CAMSAP1	2.69e-05	861	114	12	36931259
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KPNA4 GPI RRP1B DNAAF4 PDLIM7 XPO4 NOMO1 KIAA1671 KSR1 MTOR PSMG1 IQCB1 SEC16A SMAD9 KPNA3	2.81e-05	1321	114	15	27173435
Pubmed	Nuclear localization signal in a cancer-related transcriptional regulator protein NAC1.	KPNA4 KPNA3	3.19e-05	3	114	2	22665369
Pubmed	Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation.	LEPR STAT3	3.19e-05	3	114	2	22124464
Pubmed	The insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth.	SLC25A33 MTOR	3.19e-05	3	114	2	17596519
Pubmed	MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.	MUC16 MTOR	3.19e-05	3	114	2	26046375
Pubmed	Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway.	STAT3 MTOR	3.19e-05	3	114	2	23329839
Pubmed	STAT3 signalling is required for leptin regulation of energy balance but not reproduction.	LEPR STAT3	3.19e-05	3	114	2	12594516
Pubmed	MiR-1 inhibits prostate cancer PC3 cells proliferation through the Akt/mTOR signaling pathway by binding to c-Met.	FSD1 MTOR	3.19e-05	3	114	2	30551391
Pubmed	The LINC00501-HSP90B1-STAT3 positive feedback loop promotes malignant behavior in gastric cancer cells.	HSP90B1 STAT3	3.19e-05	3	114	2	37156452
Pubmed	Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.	MTOR FBXO32	3.19e-05	3	114	2	24002653
Pubmed	Tyrosine phosphorylation of STAT3 by leptin through leptin receptor in mouse metaphase 2 stage oocyte.	LEPR STAT3	3.19e-05	3	114	2	10080923
Pubmed	Immunoexpression of DNA base excision repair and nucleotide excision repair proteins in ameloblastomas, syndromic and non-syndromic odontogenic keratocysts and dentigerous cysts.	ERCC4 XRCC1	3.19e-05	3	114	2	31862643
Pubmed	Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.	P2RY12 MTOR	3.19e-05	3	114	2	24612393
Pubmed	Interaction of tissue transglutaminase with nuclear transport protein importin-alpha3.	KPNA4 KPNA3	3.19e-05	3	114	2	10100610
Pubmed	DNA base excision repair and nucleotide excision repair proteins in malignant salivary gland tumors.	ERCC4 XRCC1	3.19e-05	3	114	2	33202356
Pubmed	Escherichia coli interaction with human brain microvascular endothelial cells induces signal transducer and activator of transcription 3 association with the C-terminal domain of Ec-gp96, the outer membrane protein A receptor for invasion.	HSP90B1 STAT3	3.19e-05	3	114	2	18662321
Pubmed	Regulation of hepatic six transmembrane epithelial antigen of prostate 4 (STEAP4) expression by STAT3 and CCAAT/enhancer-binding protein alpha.	STEAP4 STAT3	3.19e-05	3	114	2	20304921
Pubmed	Advanced glycation end products promote meniscal calcification by activating the mTOR-ATF4 positive feedback loop.	LEPR MTOR	3.19e-05	3	114	2	38424194
Pubmed	P-selectin glycoprotein ligand-1 regulates adhesive properties of the endothelium and leukocyte trafficking into adipose tissue.	SELPLG LEPR	3.19e-05	3	114	2	20558823
Pubmed	A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.	STAT3 MTOR	3.19e-05	3	114	2	20042677
Pubmed	mTOR/STAT-3 pathway mediates mesenchymal stem cell-secreted hepatocyte growth factor protective effects against lipopolysaccharide-induced vascular endothelial barrier dysfunction and apoptosis.	STAT3 MTOR	3.19e-05	3	114	2	30242894
Pubmed	Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.	LEPR MTOR	3.19e-05	3	114	2	31432191
Pubmed	Oroxylin A induces autophagy in human malignant glioma cells via the mTOR-STAT3-Notch signaling pathway.	STAT3 MTOR	3.19e-05	3	114	2	25213258
Pubmed	Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastoma.	MYCN MTOR	3.19e-05	3	114	2	26686971
Pubmed	DNA-repair genetic polymorphisms and breast cancer risk.	ERCC4 XRCC1	3.19e-05	3	114	2	14652281
Pubmed	HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway.	LEPR STAT3	3.19e-05	3	114	2	29249663
Pubmed	STAT3-induced upregulation of circCCDC66 facilitates the progression of non-small cell lung cancer by targeting miR-33a-5p/KPNA4 axis.	KPNA4 STAT3	3.19e-05	3	114	2	32151944
Pubmed	Effects of conventional CPB and mini-CPB on neutrophils CD162, CD166 and CD195 expression.	SELPLG ALCAM	3.19e-05	3	114	2	27625334
Pubmed	Human macrophage differentiation induces OCTN2-mediated L-carnitine transport through stimulation of mTOR-STAT3 axis.	STAT3 MTOR	3.19e-05	3	114	2	27733576
Pubmed	Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.	STAT3 MTOR	3.19e-05	3	114	2	17911267
Pubmed	STAT3-miR-17/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice.	LEPR STAT3	3.19e-05	3	114	2	31738412
Pubmed	[IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].	STAT3 MTOR	3.19e-05	3	114	2	27363263
Pubmed	Shigella Effector OspB Activates mTORC1 in a Manner That Depends on IQGAP1 and Promotes Cell Proliferation.	OSBP MTOR	3.19e-05	3	114	2	26473364
Pubmed	Defective STAT signaling by the leptin receptor in diabetic mice.	LEPR STAT3	3.19e-05	3	114	2	8692797
Pubmed	Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.	LEPR STAT3	3.19e-05	3	114	2	17095713
Interaction	BTNL8 interactions	RNF130 TM2D3 LEPR PTK7 OSBP	6.73e-06	47	114	5	int:BTNL8
GeneFamily	I-BAR domain containing	BAIAP2L1 BAIAP2L2	1.47e-04	5	70	2	1287
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	SLC26A4 STEAP4 ADGRV1 BAIAP2L1 RASEF ROS1 ALCAM B4GALNT3 WWC1	1.24e-09	185	114	9	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SPATA6L CYP4B1 ADGRV1 BAIAP2L1 RASEF ROS1 ALCAM B4GALNT3 WWC1	1.42e-09	188	114	9	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	SPATA6L STEAP4 ADGRV1 BAIAP2L1 RASEF ROS1 ALCAM WWC1 GAREM1	1.42e-09	188	114	9	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	MUC16 STEAP4 PLEKHS1 ADGRV1 BAIAP2L1 RASEF ALCAM B4GALNT3	3.28e-08	190	114	8	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 ADGRV1 KIAA1671 BAIAP2L1 RASEF ALCAM WWC1 GAREM1	4.87e-08	200	114	8	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP4B1 RAD51AP2 FAT2 DMRT3 ALCAM BAIAP2L2 WWC1	5.41e-07	187	114	7	fe9fc21192ede2eea61f419d20ccda254569d0a6
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	CYP4B1 STEAP4 ADGRV1 RASEF ROS1 B4GALNT3 WWC1	6.24e-07	191	114	7	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	SPATA6L ADGRV1 ROS1 ALCAM B4GALNT3 WWC1 GAREM1	6.46e-07	192	114	7	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CYP4B1 PLEKHS1 ADGRV1 FAT2 BAIAP2L1 ALCAM B4GALNT3	6.46e-07	192	114	7	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SPATA6L CYP4B1 ADGRV1 RASEF ROS1 ALCAM WWC1	7.17e-07	195	114	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Control-Epithelial\|Control / Disease state, Lineage and Cell class	CYP4B1 STEAP4 ADGRV1 RASEF ROS1 B4GALNT3 WWC1	7.17e-07	195	114	7	1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCell	proximal-Epithelial-Differentiating_Basal-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP4B1 MUC16 PLEKHS1 FAT2 DMRT3 FBXO32 SLITRK6	8.22e-07	199	114	7	c607346f60e5997e757e5a31cab412ab3734377b
ToppCell	proximal-3-Epithelial-Differentiating_Basal\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP4B1 MUC16 PLEKHS1 FAT2 DMRT3 FBXO32 SLITRK6	8.22e-07	199	114	7	12e07084fc2d5d4c418df564ccc0e132b056e549
ToppCell	proximal-Epithelial-Differentiating_Basal\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CYP4B1 MUC16 PLEKHS1 FAT2 DMRT3 FBXO32 SLITRK6	8.22e-07	199	114	7	96a89a2578fad9a99c52d2cf9e26e06516a96568
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PLEKHS1 DMRT3 TPX2 SAC3D1 FBXO32 GABBR1 WWC1	8.22e-07	199	114	7	f0c289523957258d16135c04679db379d43d28d9
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYP4B1 MUC16 PLEKHS1 ADGRV1 BAIAP2L1 RASEF WWC1	8.50e-07	200	114	7	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RNF130 MUC16 ADGRV1 RASEF ALCAM WWC1 GAREM1	8.50e-07	200	114	7	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	SELPLG P2RY12 ARHGEF10L MTOR MGA GAREM1	3.84e-06	162	114	6	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NR4A2 RYR3 PTK7 RASEF ROS1 SLITRK6	4.90e-06	169	114	6	0c341f91dc21aaf92bead18d59684d11510502ce
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TECTA RYR3 PTK7 KIAA1671 GLDC B4GALNT3	5.79e-06	174	114	6	99eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MUC16 STEAP4 FAT2 ALCAM NDUFV1-DT BAIAP2L2	6.18e-06	176	114	6	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NR4A2 MUC16 STEAP4 PLEKHS1 ADGRV1 RASEF	6.39e-06	177	114	6	a4c001a8e44142babf9f24dfe6f7b73a70b11b16
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NR4A2 MUC16 STEAP4 PLEKHS1 ADGRV1 RASEF	6.39e-06	177	114	6	363e07b0f347f3716d530a28ead854b98e27d37c
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 PLEKHS1 ADGRV1 KSR1 RASEF B4GALNT3	6.81e-06	179	114	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDLIM7 RYR3 PTK7 FBXO32 SLITRK6 SMAD9	7.26e-06	181	114	6	25915e2500430a902db37d79a749ce2990b69810
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM APOB ADGRV1 PKHD1L1 RYR3 ROS1	7.97e-06	184	114	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	STEAP4 NLGN1 ADGRV1 RASEF ROS1 WWC1	7.97e-06	184	114	6	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM APOB ADGRV1 PKHD1L1 RYR3 ROS1	7.97e-06	184	114	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM APOB ADGRV1 PKHD1L1 RYR3 ROS1	7.97e-06	184	114	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COPD-Epithelial-Club\|World / Disease state, Lineage and Cell class	STEAP4 ADGRV1 RASEF ROS1 B4GALNT3 WWC1	8.48e-06	186	114	6	3006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCell	facs-Lung-18m-Epithelial-alveolar_epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC26A4 BAIAP2L1 RASEF ROS1 ALCAM WWC1	8.48e-06	186	114	6	c7214e762b3b48197fdd0b36a50a4de2550a888f
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	CYP4B1 PLEKHS1 FAT2 FBXO32 B4GALNT3 SLITRK6	8.74e-06	187	114	6	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	control-Myeloid-Neutrophils_4\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM MSRB1 PDLIM7 SMCHD1 STEAP4 ALAS2	9.01e-06	188	114	6	22d76c222fb0e3da08e10191af0090f14e03f2ad
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 ADGRV1 BAIAP2L1 RASEF WWC1 GAREM1	9.01e-06	188	114	6	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	SPATA6L STEAP4 NLGN1 ROS1 WWC1 GAREM1	9.01e-06	188	114	6	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CYP4B1 ADGRV1 RASEF ROS1 B4GALNT3 WWC1	9.29e-06	189	114	6	6f2322d017b74a1757c81d6e06f50ead8c3dd0cc
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	STEAP4 PLEKHS1 ADGRV1 FAT2 B4GALNT3 GAREM1	9.29e-06	189	114	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	IPF-Epithelial-Club\|IPF / Disease state, Lineage and Cell class	CYP4B1 STEAP4 RASEF ROS1 B4GALNT3 WWC1	9.29e-06	189	114	6	f3fcef008ef252b29ac6d567fef27f9acf9cd70f
ToppCell	368C-Epithelial_cells-Epithelial-E_(AT2)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CYP4B1 ADGRV1 RASEF ROS1 B4GALNT3 WWC1	9.29e-06	189	114	6	926b5fa3064b501a57ba78583e8af33532add455
ToppCell	Adult-Epithelial-club_cell\|Adult / Lineage, Cell type, age group and donor	STEAP4 PLEKHS1 ADGRV1 B4GALNT3 WWC1 GAREM1	9.57e-06	190	114	6	756bff697d30aec56c0ebfca94295f084a15bf37
ToppCell	368C-Epithelial_cells\|368C / Donor, Lineage, Cell class and subclass (all cells)	CYP4B1 ADGRV1 RASEF ROS1 B4GALNT3 WWC1	9.57e-06	190	114	6	459811e88d3001816c2d89034e0921c24918c17f
ToppCell	IPF-Epithelial-Club\|World / Disease state, Lineage and Cell class	CYP4B1 STEAP4 RASEF ROS1 B4GALNT3 WWC1	9.86e-06	191	114	6	3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954
ToppCell	(7)_Epithelial-E_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CYP4B1 STEAP4 ADGRV1 BAIAP2L1 RASEF ROS1	9.86e-06	191	114	6	0fc8d109d5c50957ceef5b8b8b818b0c598b1bbe
ToppCell	COPD-Epithelial\|COPD / Disease state, Lineage and Cell class	CYP4B1 ADGRV1 RASEF ROS1 B4GALNT3 WWC1	1.02e-05	192	114	6	0644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SPATA6L STEAP4 ADGRV1 ROS1 WWC1 GAREM1	1.02e-05	192	114	6	cc9911e182a289779a2612bc213daae5607689e7
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	STEAP4 PLEKHS1 ADGRV1 B4GALNT3 WWC1 GAREM1	1.05e-05	193	114	6	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	Fetal_29-31_weeks-Epithelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPATA6L ADGRV1 RASEF ROS1 ALCAM WWC1	1.05e-05	193	114	6	a0ca3231992f14abcf1a6129573bace320e89d2a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	STEAP4 ADGRV1 RASEF ROS1 ALCAM WWC1	1.08e-05	194	114	6	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 BAIAP2L1 GLDC RASEF ROS1 WWC1	1.08e-05	194	114	6	c47fc3f716ab091a39c20d7639ac783029589ee5
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYP4B1 SLC26A4 MUC16 STEAP4 PLEKHS1 ALCAM	1.14e-05	196	114	6	c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYP4B1 MUC16 PLEKHS1 FAT2 DMRT3 SLITRK6	1.14e-05	196	114	6	d9426eba69047166ffa8179f1654e011c1020328
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYP4B1 MUC16 PLEKHS1 FAT2 DMRT3 SLITRK6	1.14e-05	196	114	6	7e19919eafd6ddf547dd4e8aa532a050e182c5cc
ToppCell	(05)_Secretory\|World / shred by cell type by condition	CYP4B1 HLA-DQA2 SLC26A4 MUC16 STEAP4 PLEKHS1	1.14e-05	196	114	6	8032c25b51ef96aeba28cc52686a2bd45213453d
ToppCell	mild-Myeloid-Neutrophils_4\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MGAM MSRB1 PDLIM7 SMCHD1 STEAP4 ALAS2	1.14e-05	196	114	6	f8c98cded5550843322b1711e1a57c7e88cae861
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CYP4B1 NR4A2 ADGRV1 LRCH1 CAMTA1 WWC1	1.18e-05	197	114	6	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	COVID-19-Epithelial\|COVID-19 / Condition, Lineage and Cell class	CYP4B1 MUC16 PLEKHS1 BAIAP2L1 RASEF CCDC33	1.18e-05	197	114	6	18fd7344628a87d5c7ef5efb66e260a4136245bf
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ADGRV1 RYR3 KIAA1671 SLCO1C1 GABBR1 WWC1	1.28e-05	200	114	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Lung_Parenchyma-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYP4B1 STEAP4 ADGRV1 RASEF ROS1 WWC1	1.28e-05	200	114	6	c2bde99b3bc7a8740441c1a0c1394892b940b857
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYP4B1 STEAP4 ADGRV1 RASEF ROS1 WWC1	1.28e-05	200	114	6	3ff9abd5e07780a59d5571da906fa15f00a1d5c2
ToppCell	Biopsy_Other_PF-Epithelial\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CYP4B1 STEAP4 BAIAP2L1 RASEF ROS1 WWC1	1.28e-05	200	114	6	1ef4d5ae698fa721e0f510bf0d918bd8d3b00591
ToppCell	Parenchymal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CYP4B1 STEAP4 BAIAP2L1 RASEF ROS1 WWC1	1.28e-05	200	114	6	4e5b6cb014d9bcb58e13c7511c86c43e27c496e4
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CYP4B1 STEAP4 ADGRV1 RASEF ROS1 WWC1	1.28e-05	200	114	6	9970e9bde6aa2ff3aef60dcb065ff15b7463e147
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tshz2-Nrep_(Subiculum_and_Entorhinal_Cortex)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DMRT3 ALAS2 TRPM1 CCDC33	1.30e-05	56	114	4	7b7aaa514a3e85250d6279e0770a9409c4b0b199
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Tshz2-Nrep_(Subiculum_and_Entorhinal_Cortex)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	DMRT3 ALAS2 TRPM1 CCDC33	1.30e-05	56	114	4	17c37bdd1f9733c3823e98ed4d1cd0ca9db66e9c
ToppCell	LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 TEX15 NCDN TPX2 ALAS2	2.64e-05	136	114	5	a2063abe2d7c3277bfbe1514c8c66363cf04b248
ToppCell	LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 TEX15 NCDN TPX2 ALAS2	2.74e-05	137	114	5	8e2fa2ef8becace96a68bb85c002329110902fbb
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	NR4A2 RYR3 KIAA1671 XYLT1 GAREM1	3.83e-05	147	114	5	8f725ff8fb4ced5db2643e80669d3f7945b820ab
ToppCell	mild-Myeloid-Neutrophils_4\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MYCN MSRB1 SMCHD1 STEAP4 ALAS2	4.22e-05	150	114	5	979566663d1110475f1e017c2f9890aca4b6f701
ToppCell	facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM MSRB1 PDLIM7 STEAP4 B4GALNT3	5.25e-05	157	114	5	9d4308312301cb922f156a7b6aededc9e1c62807
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 TECTA PKHD1L1 RYR3 RXFP2	5.74e-05	160	114	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 TECTA PKHD1L1 RYR3 RXFP2	5.74e-05	160	114	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LINC00473 ARHGEF10L GLDC B4GALNT3 GAREM1	6.45e-05	164	114	5	6fb2136168f430babfeb81ca7e151ca7a8092ec4
ToppCell	LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYCN CIC KIAA1671 KSR1 TDRD10	6.83e-05	166	114	5	3b750d4023a0a09d86113aae5a97d84391f7b482
ToppCell	Control-Epithelial-Mesothelial\|Control / Disease state, Lineage and Cell class	LINC00473 MUC16 NLGN1 PKHD1L1 WWC1	6.83e-05	166	114	5	1ed3788257e14f097862b999f020bfe2a57de52b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NR4A2 RYR3 RASEF ROS1 SLITRK6	7.03e-05	167	114	5	a6ff7a3d9b80839c0efa91658836812e868561fa
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLC26A4 NR4A2 NCDN RYR3 GAREM1	7.23e-05	168	114	5	6db453cbbbaf4144a86fadcfa5805d33396713b5
ToppCell	Control\|World / group, cell type (main and fine annotations)	STEAP4 ADGRV1 BAIAP2L1 RASEF ROS1	7.23e-05	168	114	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	IIF\|World / Disease, Lineage and Cell Type	HLA-DQA2 NR4A2 XPO4 STAT3 ALAS2	7.43e-05	169	114	5	ebf726f725079317ad67c2f754748b4112607277
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLGN1 ADGRV1 PKHD1L1 RYR3 ALAS2	7.43e-05	169	114	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NR4A2 PTK7 RASEF ROS1 SLITRK6	8.08e-05	172	114	5	adc09c4d1b63fe84150516beb692db1e7f7ac980
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NR4A2 PTK7 RASEF ROS1 SLITRK6	8.08e-05	172	114	5	cecfe5cf20f317ea01b4604789e07a14481c4cd6
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SELPLG DNAAF4 SLC25A33 TESPA1 TPX2	8.08e-05	172	114	5	282017db72d0537ac82aecc69393ccde9590be60
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDLIM7 NLGN1 ARHGEF10L SACS FBXO32	8.30e-05	173	114	5	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MYCN MUC16 PLEKHS1 FAT2 RASEF	8.53e-05	174	114	5	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	XPO4 TEX15 RXFP2 RASEF ALCAM	8.76e-05	175	114	5	442f261a3b2c4d2523f7d4089178f8c79cac2f0f
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	XPO4 TEX15 RXFP2 RASEF ALCAM	8.76e-05	175	114	5	35fb7735dd3355476fe60404833cb60bd066bcf1
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NR4A2 PTK7 RASEF ROS1 SLITRK6	9.00e-05	176	114	5	ed421d8525108d2f585265d2cf777f07b29f44f0
ToppCell	LA-17._Lymphocyte\|World / Chamber and Cluster_Paper	SELPLG RNF130 RUNX3 TESPA1 ALAS2	9.49e-05	178	114	5	34ec499d03cc198cfefa19a724d4c81974052f65
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|390C / Donor, Lineage, Cell class and subclass (all cells)	CYP4B1 MUC16 PLEKHS1 DMRT3 SLITRK6	9.49e-05	178	114	5	fce60ce6b662f1bdaa3b4da43800c6c22fe89533
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	CYP4B1 MUC16 PLEKHS1 DMRT3 SLITRK6	9.49e-05	178	114	5	b19c906e067b07eadfd68934d9330b447e24c708
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR3A SMCHD1 NR4A2 RUNX3 TDRD10	9.75e-05	179	114	5	fad1fbee002fcd424c03460d695559060ce41a3f
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NLGN1 ADGRV1 RAD51AP2 BAIAP2L1 WWC1	9.75e-05	179	114	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	APOB TEX15 BAIAP2L1 ALCAM WWC1	9.75e-05	179	114	5	bf012825e88626e59cd1deebf67c2cd269ce4829
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TEX15 RYR3 PTK7 RXFP2 B4GALNT3	9.75e-05	179	114	5	f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR3A SMCHD1 NR4A2 RUNX3 TDRD10	9.75e-05	179	114	5	6d4e4b64e633b2ae8514ffa1e45829d6508dac54
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR3A SMCHD1 NR4A2 RUNX3 TDRD10	9.75e-05	179	114	5	61a7cc01fae4115325fce0efaa5bacf8f9af5ba2
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Ly6g5b+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TECTA VWA7 RUNX3 TESPA1 GABBR1	1.00e-04	180	114	5	81c7086399256260e59424b7410feec514ce8027
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF130 P2RY12 HLA-DQA2 NLGN1 SAC3D1	1.00e-04	180	114	5	fb8bc639f7f94e7aed9f9d708d5d5c78178533ae
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	STEAP4 ADGRV1 RASEF ROS1 GAREM1	1.00e-04	180	114	5	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYCN FSD1 TESPA1 RYR3 PSMG1	1.03e-04	181	114	5	ee207ea171e2ffc22a7f850be57bb118a87e0f81
Drug	tetraethylenepentamine pentahydrochloride; Down 200; 100uM; MCF7; HG-U133A	ERCC4 RRP1B PDLIM7 DHX38 FSD1 XRCC1 ARHGEF10L OSBP	6.01e-06	197	112	8	574_DN
Drug	Nadide [53-84-9]; Down 200; 6uM; HL60; HT_HG-U133A	ERCC4 ANK2 PDLIM7 NR4A2 TESPA1 NCDN WDR91 CAMSAP1	6.23e-06	198	112	8	2529_DN
Disease	type 2 diabetes mellitus (is_implicated_in)	P2RY12 APOB LEPR STAT3 MTOR PARL	4.75e-05	171	111	6	DOID:9352 (is_implicated_in)
Disease	ovarian cancer (is_implicated_in)	MUC16 APOB RUNX3 STAT3	5.99e-05	56	111	4	DOID:2394 (is_implicated_in)
Disease	Colorectal Carcinoma	ANK2 NR4A2 APOB XRCC1 NCDN ARHGEF10L KMT2C OSBP SACS TPX2 SMAD9	7.01e-05	702	111	11	C0009402
Disease	glycoprotein measurement	CTDSPL2 APOB ADGRV1 RUNX3 LEPR	8.94e-05	119	111	5	EFO_0004555
Disease	systemic scleroderma, Crohn's disease	STAT3 GGNBP1	1.39e-04	5	111	2	EFO_0000384, EFO_0000717
Disease	aortic valve stenosis (is_implicated_in)	APOB PPP3CB	1.39e-04	5	111	2	DOID:1712 (is_implicated_in)
Disease	muscular atrophy (implicated_via_orthology)	MTOR FBXO32	2.91e-04	7	111	2	DOID:767 (implicated_via_orthology)
Disease	marginal zone B-cell lymphoma	PSG1 APOB	3.87e-04	8	111	2	EFO_1000630
Disease	tyrosine-protein kinase receptor TYRO3 measurement	MGAM MGA	3.87e-04	8	111	2	EFO_0020829
Disease	nucleus accumbens volume change measurement	MUC16 WWC1	7.54e-04	11	111	2	EFO_0021493
Disease	invasive ductal carcinoma (is_implicated_in)	XRCC1 RUNX3	7.54e-04	11	111	2	DOID:3008 (is_implicated_in)
Disease	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	STAT3 MGA	9.03e-04	12	111	2	C0023485
Disease	Carcinoma, Granular Cell	RUNX3 STAT3 KMT2C MTOR	9.82e-04	116	111	4	C0205644
Disease	Adenocarcinoma, Tubular	RUNX3 STAT3 KMT2C MTOR	9.82e-04	116	111	4	C0205645
Disease	Adenocarcinoma, Oxyphilic	RUNX3 STAT3 KMT2C MTOR	9.82e-04	116	111	4	C0205642
Disease	Carcinoma, Cribriform	RUNX3 STAT3 KMT2C MTOR	9.82e-04	116	111	4	C0205643
Disease	Adenocarcinoma, Basal Cell	RUNX3 STAT3 KMT2C MTOR	9.82e-04	116	111	4	C0205641
Disease	Adenocarcinoma	RUNX3 STAT3 KMT2C MTOR	9.82e-04	116	111	4	C0001418
Disease	gallbladder cancer (is_implicated_in)	APOB XRCC1	1.06e-03	13	111	2	DOID:3121 (is_implicated_in)
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	NR4A2 STAT3 RNF103 CAMSAP1	1.54e-03	131	111	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	NR4A2 STAT3 RNF103 CAMSAP1	1.54e-03	131	111	4	C4552091
Disease	Juvenile arthritis	NR4A2 STAT3 RNF103 CAMSAP1	1.54e-03	131	111	4	C3495559
Disease	Juvenile psoriatic arthritis	NR4A2 STAT3 RNF103 CAMSAP1	1.54e-03	131	111	4	C3714758
Disease	idiopathic scoliosis (implicated_via_orthology)	RUNX3 PTK7	1.63e-03	16	111	2	DOID:0060250 (implicated_via_orthology)
Disease	T-Cell Lymphoma	STAT3 MGA	1.63e-03	16	111	2	C0079772
Disease	ovarian neoplasm	ERCC4 MUC16 STAT3 MTOR	1.67e-03	134	111	4	C0919267
Disease	Juvenile-Onset Still Disease	NR4A2 STAT3 RNF103 CAMSAP1	1.72e-03	135	111	4	C0087031
Disease	Malignant neoplasm of ovary	ERCC4 MUC16 STAT3 MTOR	1.81e-03	137	111	4	C1140680
Disease	Lipidemias	APOB LEPR	1.84e-03	17	111	2	C1706412
Disease	Hyperlipidemia	APOB LEPR	1.84e-03	17	111	2	C0020473
Disease	Bladder Neoplasm	ERCC4 CYP4B1 KMT2C MTOR	1.96e-03	140	111	4	C0005695
Disease	Malignant neoplasm of urinary bladder	ERCC4 CYP4B1 KMT2C MTOR	2.01e-03	141	111	4	C0005684
Disease	squamous cell carcinoma (is_implicated_in)	STAT3 KMT2C	2.06e-03	18	111	2	DOID:1749 (is_implicated_in)
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAAF4 SLITRK6	2.30e-03	19	111	2	DOID:10003 (implicated_via_orthology)
Disease	Prostatic Neoplasms	RNF130 HSP90B1 SLC26A4 STEAP4 XRCC1 STAT3 KMT2C MGA	2.32e-03	616	111	8	C0033578
Disease	Malignant neoplasm of prostate	RNF130 HSP90B1 SLC26A4 STEAP4 XRCC1 STAT3 KMT2C MGA	2.32e-03	616	111	8	C0376358
Disease	progression free survival, ovarian serous carcinoma	MGAM MGA	3.08e-03	22	111	2	EFO_0004920, EFO_1001516
Disease	Dyslipidemias	APOB LEPR	3.67e-03	24	111	2	C0242339
Disease	Dyslipoproteinemias	APOB LEPR	3.67e-03	24	111	2	C0598784

Protein segments in the cluster

Peptide	Gene	Start	Entry
KFPSGPLLTSVRFSN	C2orf16	36	Q68DN1
IFSLNRPSPRTVKSF	ARHGEF10L	841	Q9HCE6
PPGERSFSFTTVLTK	CAMTA1	516	Q9Y6Y1
PRTTLLGTIFSPVFN	CTDSPL2	136	Q05D32
PGQSLTLTRSKFIFT	CCDC33	86	Q8N5R6
LLAPFSKRNSTASFP	B4GALNT3	486	Q6L9W6
ASSRKPFGILSPNVL	FBXO34	56	Q9NWN3
LPPNSGERVSFKITL	HTR3A	266	P46098
LTPETGSLNSFPKRF	ADGRV1	5581	Q8WXG9
DPTLTGPRKQSAFSI	CFAP92	366	Q9ULG3
PVPISNATKRSFLGS	CAMSAP1	361	Q5T5Y3
LSPRPFKGLLVSTNA	RAD51AP2	66	Q09MP3
AETRAGLTLKPQTFP	NOMO3	471	P69849
LGTLNKSSSTPFPFR	PAAT	246	Q9H8K7
ISPGNTISRSSPKFI	RASEF	376	Q8IZ41
PPKNFSRGSLVFVSI	RNF130	186	Q86XS8
TKPSNSLIPFLSFRS	CDC42BPG	806	Q6DT37
GNKATFSPIVTLEPR	ANK2	1211	Q01484
TATGPVLLPFTLNFT	MUC16	13316	Q8WXI7
LRPLFKNTSVGPLYS	MUC16	13826	Q8WXI7
PKSGLAFSRPSQLST	FBXW9	41	Q5XUX1
TVFSKFPVTLGQPNT	HLA-DQA2	116	P01906
AETRAGLTLKPQTFP	NOMO2	471	Q5JPE7
SFISPSIPITFLRNV	KPNA3	206	O00505
IRSFPLSSPISKFLN	MDN1	3761	Q9NU22
DQFPKSLGLSRSPVV	KMT2C	1976	Q8NEZ4
TSSPLFNKAVFLRPS	KIAA1671	126	Q9BY89
GFTFPNRLLTTKEAP	NCDN	81	Q9UBB6
TSTGFTAQLKRLPSP	MGAM2	101	Q2M2H8
TLAGTQKFSIRPSPV	MGA	1561	Q8IWI9
RAFISKVPPGSRATF	MGA	2861	Q8IWI9
GSTIIRSKTFSPGPQ	WWC1	921	Q8IX03
PPNKAFRSTDTVGFL	GGNBP1	21	Q5YKI7
GSPPADQTLVIKTFR	GABBR1	571	Q9UBS5
TFKTRFTQPLLPAFT	FSD1	446	Q9BTV5
FTARLKNLPSSPVFG	MGAM	151	O43451
TLSPKFAGFPALINR	MGAM	2186	O43451
GTNPFATVKLRPTIT	BAIAP2L2	506	Q6UXY1
LKRPFINLTAGQPTS	FAT2	621	Q9NYQ8
VFQLLPSFPTLTRSK	KSR1	296	Q8IVT5
LPFQCKGRFSTRSPL	GAREM1	211	Q9H706
AETRAGLTLKPQTFP	NOMO1	471	Q15155
STAPFGLKPRSVFLR	LRCH1	541	Q9Y2L9
FPPKILTSVGSNVSF	LEPR	336	P48357
NRPTNSIVFTKLTPF	GPI	471	P06744
ALFGKTRVSPIFPFS	PCOTH	26	Q58A44
FRPTRKNSVPVTSAF	NLGN1	676	Q8N2Q7
TTRPFKTSNPKNLLG	P2RY12	126	Q9H244
TTVFRTSKPFNPLLG	OSBP	486	P22059
GKDFNVPLSISRLTP	PDLIM7	21	Q9NR12
SLVSVSLRKPFSGPQ	ALAS2	106	P22557
TGSLPSPFLRALKTQ	PSMG1	181	O95456
VTFKSILFVPTSAPR	HSP90B1	381	P14625
SIKFSVPAGIVIPSF	APOB	3866	P04114
LSGENPFATVKLRPT	BAIAP2L1	486	Q9UHR4
FPRLFGPTLSAKIQF	LINC00473	151	A8K010
SGTVSLPFSLKANRP	DMRT3	236	Q9NQL9
GSIKINFTPRVFPTA	DNAAF4	236	Q8WXU2
FKLFSTPSPVIRSTA	IQCB1	216	Q15051
QLSKPVTFVDGRSLP	CYP4B1	386	P13584
TPARAGFSSKQTLFP	FAM135B	1051	Q49AJ0
TRPAFKGLTFTDLPL	FBXO32	216	Q969P5
RKSQTTGFPSLITIF	PPP3CB	301	P16298
PPAFFSALSIKFTGR	RNF103	246	O00237
RFARAFSTPKGQTLP	SAC3D1	306	A6NKF1
QTIRFLPFLTKPAGF	SACS	2211	Q9NZJ4
PDGSPVFIAFRSSTK	ALCAM	61	Q13740
SQFLQKSPLPTKRGT	HMCES	316	Q96FZ2
GRFTFTLHLETPKPS	PSG1	136	P11464
PGRFFSSQIPSSVNK	ERCC6L	1071	Q2NKX8
SFSPVAGPNKLFIRL	MPHOSPH8	826	Q99549
FGTKPRHITPFTSFQ	MTOR	306	P42345
RSLIKPLFFTVGFTG	PARL	96	Q9H300
QSRFUIFSSSLKFVP	MSRB1	91	Q9NZV6
SRLSLFSFKQSPPGT	NR4A2	171	P43354
RGKSFTLTITVFTNP	RUNX3	146	Q13761
PTPGSKLSLRNFIEF	RTL1	801	A6NKG5
PTTKRGLFIPFSVSS	SELPLG	276	Q14242
FPGIAPKIEFSTRTA	SPATA6L	116	Q8N4H0
GQTLPLFFTAKEPSR	SERGEF	191	Q9UGK8
KSILVSPTGPSRVAF	RRP1B	701	Q14684
FTLFKGVITRPDLPS	SMCHD1	576	A6NHR9
VCNSPPFFKGSILSR	SLITRK6	246	Q9H5Y7
AGLLVTSIVPKTPFF	TDRD10	196	Q5VZ19
SSSPTEGFLLKPVFL	SIN3B	1001	O75182
FPFSNIRPGKRQTSV	RXFP2	526	Q8WXD0
RPTSVTPGLFQVLKS	SLC25A33	66	Q9BSK2
PISSLFSFTSPAVKR	SMAD9	6	O15198
SIRFTLPPGTSTNGK	CIC	861	Q96RK0
LPSEQSSRPFGLAFK	NDUFV1-DT	171	Q8NBR9
LTNFFSLPGSRTPEI	TECTA	216	O75443
NKRTLFYSSPLLGPS	PLEKHS1	146	Q5SXH7
KIASPPSDFGRLQFS	XYLT1	726	Q86Y38
KQFASRSPPLNFLSS	XPO4	731	Q9C0E2
TFTITVRPKNAALGP	MYCN	296	P04198
SVGSRRGFFTKLPPA	TMEM143	216	Q96AN5
FDGKFANLTPSRTVP	SEC16A	2046	O15027
SPQPESGIKRLFSFF	RILPL1	346	Q5EBL4
EPQGVKILRFSSPIF	SLC26A4	541	O43511
LKPGFRFSTPCFVVT	RYR3	1661	Q15413
AILSTKPPGTFLLRF	STAT3	596	P40763
LFCKTSVQPVGRPSF	SLCO1C1	11	Q9NYB5
VFGSRNPQKTTLLPS	STEAP4	46	Q687X5
GRTFPVDILFSKTPQ	DHX38	706	Q92620
FTIIQTSLKPLPGNF	ROS1	926	P08922
TFLNGSRIPVTEKAP	PKHD1L1	3726	Q86WI1
SVKPDQTLGFPSLRS	TRPM1	1536	Q7Z4N2
RPGALFFSRINKTSP	XRCC1	186	P18887
IPARFFTTPSQAKGI	TESPA1	181	A2RU30
FDPSKPFSLTSRGAL	ERCC4	761	Q92889
KITNIFRPGFSPTAD	TEX15	776	Q9BXT5
PKPSELLGTRATFFL	TGM7	66	Q96PF1
KVPLSLRIASFSGPQ	VWA7	741	Q9Y334
SPRVGFLSSLLPQSK	WDR91	256	A4D1P6
FPRSSLQPITTLGKS	PTK7	791	Q13308
LGALDKLSSTPFPFR	nan	81	Q499Y3
KLSSTPFPFRTGLTS	nan	86	Q499Y3
LAQSIKDPGPTRTFT	TM2D3	36	Q9BRN9
QPLTVPVSPKFSTRF	TPX2	731	Q9ULW0
RGIPGSVFKRTSPFL	GLDC	506	P23378
SFISPSIPITFLRNV	KPNA4	206	O00629